ScoreWhy is Sudarshan Pharma Industries Ltd ?
1
Flat results in Sep 25
- PBT LESS OI(Q) At Rs 2.74 cr has Fallen at -42.8% (vs previous 4Q average)
- NON-OPERATING INCOME(Q) is 43.27 % of Profit Before Tax (PBT)
2
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -1.01% over the previous quarter and collectively hold 19.83% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
3
Below par performance in long term as well as near term
- Along with generating -48.80% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Specialty Chemicals)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sudarshan Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sudarshan Pharma
-50.16%
-1.00
48.98%
Sensex
8.69%
0.75
11.31%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
27.70%
EBIT Growth (5y)
51.12%
EBIT to Interest (avg)
2.42
Debt to EBITDA (avg)
5.22
Net Debt to Equity (avg)
1.54
Sales to Capital Employed (avg)
1.53
Tax Ratio
25.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
20.84%
ROCE (avg)
10.65%
ROE (avg)
12.34%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
34
Industry P/E
33
Price to Book Value
3.97
EV to EBIT
21.92
EV to EBITDA
20.35
EV to Capital Employed
2.17
EV to Sales
1.52
PEG Ratio
0.82
Dividend Yield
NA
ROCE (Latest)
9.90%
ROE (Latest)
11.61%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend6What is working for the Company
OPERATING CF(Y)
Highest at Rs 34.91 Cr
NET SALES(Q)
Highest at Rs 167.01 cr
EPS(Q)
Highest at Rs 1.83
-4What is not working for the Company
PBT LESS OI(Q)
At Rs 2.74 cr has Fallen at -42.8% (vs previous 4Q average
NON-OPERATING INCOME(Q)
is 43.27 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Sudarshan Pharma
Operating Cash Flow - Annually
Highest at Rs 34.91 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Net Sales - Quarterly
Highest at Rs 167.01 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 167.01 cr has Grown at 26.2% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 132.31 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 1.83
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Sudarshan Pharma
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.74 cr has Fallen at -42.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 4.79 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 43.27 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
